Recto, Analyn .
HRN: 22-59-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/15/2023
02/22/2023
IV
500 Mg
Every 8 Hours
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes